Skip to content

Clinical trials

Phase 1 Hepatitis C trials in Puerto Rico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 1 Country / region: Puerto Rico Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20074
20103
20113
20122
20132
20141
20161

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences7
National Institute of Allergy and Infectious Diseases (NIAID)2
Akros Pharma Inc.1
Bristol-Myers Squibb1
GlaxoSmithKline1
Idera Pharmaceuticals, Inc.1
Intarcia Therapeutics1
National Cancer Institute (NCI)1
Vertex Pharmaceuticals Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C16
Hepatitis C, Chronic6
Liver Diseases2
Carcinoma, Hepatocellular1
Digestive System Diseases1
Enterovirus Infections1
Flaviviridae Infections1
HIV Infections1
Hepatitis1
Hepatitis, Chronic1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.